Royalty Pharma plc (RPRX) dividend: yield, history and safety
Price $69.31 · data as of November 13, 2026
Dividend at a glance
Dividend yield1.36%
Annual dividend (est.)$0.94
5-year growth per year+17.5%
Payout ratio (EPS)38%
FCF covers dividend—
Years paid (our data)6
Dividend safety: weak
Royalty Pharma passes 2 of 5 checks.
- Free cash flow covers the dividend
- Pays out less than 75% of earnings
- Dividend raised in most of the last 5 years
- Debt under 3 years of free cash flow
- Paid for at least 10 years in a row
Dividend history
| Fiscal year | Dividend per share | Change | Total paid | Payout ratio |
|---|---|---|---|---|
| 2025 | $0.67 | +5.8% | $378M | 38% |
| 2024 | $0.63 | +6.6% | $376M | 33% |
| 2023 | $0.59 | −21.9% | $358M | 23% |
| 2022 | $0.76 | +10.7% | $333M | 761% |
| 2021 | $0.69 | +129.5% | $285M | 46% |
| 2020 | $0.30 | — | $112M | 23% |
From Royalty Pharma’s annual reports to the SEC; per-share figures adjusted for stock splits. Raised in 4 of the last 5 years.
Frequently asked questions
What is Royalty Pharma’s dividend yield?
About 1.36% at the current price of $69.31, or roughly $0.94 per share a year.
Is Royalty Pharma’s dividend safe?
Royalty Pharma passes 2 of our 5 dividend safety checks (weak).
How fast does Royalty Pharma raise its dividend?
The dividend per share grew about 17.5% a year over the last 5 years.
Built from SEC filings and market prices, rebuilt daily. Not investment advice. See the best dividend stocks